³Ô¹ÏÍøÕ¾

Latest

Latest autoimmune diseases News

  • Latest autoimmune diseases news stories and updates. What is happening today? All recent autoimmune diseases news and developments. Live coverage and timeline of autoimmune diseases. All you need to know about autoimmune diseases.
Zenas BioPharma to Participate in Upcoming Healthcare Investor Conferences
US FDA Accepts Biologics License Application (BLA) for HLX14, Biosimilar Candidate of PROLIA/XGEVA (denosumab)
New treatment for boosting immune tolerance offers hope for early pregnancy loss
Playing in mud and dirt can boost your child’s immune system – here’s how
Unique immune response in lupus paves the way for new treatments
Athos Announces Positive Topline Phase 1 Data for its AI-Generated, Novel, Oral G9A Inhibitor ATH-063, Demonstrating Selective Expansion and Activation of Potent…
KI-Mayo Clinic: Better Together For 30 Years
Untreated ADHD Is Costly Affair
$11.7m Boost For Seven Startups With Great Promise
New cheaper medicines for autoimmune conditions, cancer and heart disease
Scan Reveals ‘shock’ Find In Cancer Patient’s Neck
Is stress turning my hair grey?
Primary Endpoint Met in Phase 3 Comparative Clinical Study of Perjeta® (pertuzumab) Biosimilar Candidate HLX11
Immutep receives $3.6 million R&D tax incentive from French Government
Monash Study Finds Increased Risk of Autoimmune Disease in Stone Bench-Top Industry, Raising Concerns for Screening
Seeking to understand how nerve signals regulate inflammation
New research explains differences between men’s and women’s immune systems
The indoor microbiome: mounting research is revealing how the microbes in your home can influence your health
New CRE Targets Autoinflammatory Disease
UQ Recognised In Life Sciences Queensland Awards
Ministry of Health, Labour and Welfare in Japan Approves Partial Change Application for Moderna’s COVID-19 mRNA Vaccine Targeting SARS-COV-2 Variant JN.1
Noxopharm targets clinical trial for first-in-class investigative therapy
Immutep announces first participant dosed in Phase 1 study of IMP761
Eye-opening discovery offers fresh hope for disease that can cause blindness
The human virome: why viruses could be as important for good health as gut bacteria
Designing Healthier Cities With Good Bacteria
Immutep reports topline results from TACTI-003 Phase 2b trial
RoslinCT Appoints Professor Sir Peter Mathieson and Alexander Vos as New Non-Executive Directors
Immutep signs exclusive license agreement with Cardiff University for anti-LAG-3 molecules
How Cell Death Affects Your Health
Groundbreaking cancer treatment may trigger more cancer – but here’s why you shouldn’t worry
Epstein-Barr virus: how does a common infection trick the immune system into attacking the brain in people with MS?
Ultra-processed foods: here’s how they may affect the way the immune system functions
Putting Brakes On Chronic Inflammation
Scar formation after spinal cord injury is more complex than previously thought
Key To Improving Cancer Treatments Discovered
Bad weather, hills and the dark deter cyclists, particularly women. So what can we do about it?
European Medicines Agency (EMA) Validates Henlius and Organon Filings for Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14
Nightmares could be an early warning sign of an autoimmune disease flare-up – new study
Nightmares could be an early warning sign of autoimmune disease flare-up – new study
Unlocking the body’s defences: understanding immunotherapy
Common Type Of Fiber May Trigger Bowel Inflammation
Immutep appoints research institute to conduct first-in-human study of IMP761
To Arrest Illness At Early Stage
Hope For Treating Autoimmune Diseases
New research investigates the genetics of circulating vitamin A
Rare Disease Provides Broader Knowledge
Digital Twin Allows For Tailored Medication

© 2024 - ³Ô¹ÏÍøÕ¾